The ISHLT/HFSA Guideline on Acute Mechanical Circulatory Support
Published 6 February 2023
Alexander M. Bernhardt, MD; Hannah Copeland, MD; Anita Deswal, MD, MPH; Jason Gluck, DO; Michael M. Givertz, MD
J Heart Lung Transplant Apr 2023;42(4):E1-64.
In spite of medical advances, cardiogenic and pulmonary shock are associated with high mortality and morbidity. The availability and use of acute or temporary mechanical support devices has grown over the years, with the goal of improving patient outcomes
by temporarily providing support to allow time for organ recovery or for longer-term decisions including transition to durable therapies.
A collaborative effort commissioned by the International Society for Heart & Lung Transplantation (ISHLT) and the Heart Failure Society of America (HFSA) has developed this critically-needed critically-needed guideline for the management of patients requiring acute mechanical circulatory support (MCS).
The document covers:
- Definitions of cardiogenic and pulmonary shock
- Medical treatment and surgical interventions
- Management of patients supported with temporary devices
- Complications
- Special populations
- Social and ethical dilemmas
The writing groups for this document included multidisciplinary members from both societies with a focus on diversity in gender, geography, area of expertise, and level of seniority. This document is perfect for cardiologists, especially interventional and advanced heart failure, pulmonary-critical care specialists, intensivists, cardiothoracic surgeons, as well as referring providers.
Read at JHLTRelated Guidlines
-
Diagnosis and Management of Bronchiolitis Obliterans Syndrome
-
2019 Updated Consensus Statement on the Diagnosis and Treatment of Pediatric Pulmonary Hypertension
-
Destination Mechanical Circulatory Support: Proposal for Clinical Standards
-
Generic Drug Immunosuppression in Thoracic Transplantation
-
2009 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension